Azafaros

Leiden, The Netherlands

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

$146.7M raised

May 2025

Series B

Top Investors

Schroders CapitalJeito CapitalBioGeneration VenturesPictet Alternative AdvisorsForbion Capital Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Azafaros raised?

Azafaros has raised $146.7M in total funding. The most recent round was Series B. The last funding was announced in May 2025.

Who are Azafaros's investors?

Azafaros's investors include Schroders Capital, Jeito Capital, BioGeneration Ventures, Pictet Alternative Advisors, Forbion Capital Partners.

Where is Azafaros headquartered?

Azafaros is headquartered in Leiden, The Netherlands.

What does Azafaros do?

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

What stage is Azafaros at?

Azafaros is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 13, 2025.

MLA

"Azafaros — Funding & Investors." VCBacked, May 13, 2025, https://www.vcbacked.co/company/azafaros. Accessed June 3, 2026.

APA

VCBacked. (2025). Azafaros — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/azafaros

Wikipedia (cite web)

{{cite web |title=Azafaros — Funding & Investors |url=https://www.vcbacked.co/company/azafaros |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 13, 2025.